Global Nanotechnology in Drug Delivery 麻豆原创 Research Report 2023

Publication ID:

PB503234602

Publication Date:

March 21, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Drug Delivery Systems (DDS) refers to the different Delivery forms of various therapeutic drugs adopted by people in the process of disease prevention and treatment, which were called dosage forms in pharmacy before the 1960s.
Highlights
The global Nanotechnology in Drug Delivery market was valued at US$ 6890.9 million in 2022 and is anticipated to reach US$ 10400 million by 2029, witnessing a CAGR of 7.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising demand from Asia-Pacific region a major driver for the growth of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nanotechnology in Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology in Drug Delivery.
The Nanotechnology in Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nanotechnology in Drug Delivery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanotechnology in Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Access Pharmaceuticals
Alkermes
Aquanova
Camurus
Capsulution Pharma
Celgene
Segment by Type
Targeted Delivery
Drug Package
Segment by Application
Cancer
Tumor
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanotechnology in Drug Delivery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Nanotechnology in Drug Delivery 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Targeted Delivery
1.2.3 Drug Package
1.3 麻豆原创 by Application
1.3.1 Global Nanotechnology in Drug Delivery 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Tumor
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology in Drug Delivery 麻豆原创 Perspective (2018-2029)
2.2 Nanotechnology in Drug Delivery Growth Trends by Region
2.2.1 Global Nanotechnology in Drug Delivery 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nanotechnology in Drug Delivery Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Nanotechnology in Drug Delivery Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Nanotechnology in Drug Delivery 麻豆原创 Dynamics
2.3.1 Nanotechnology in Drug Delivery Industry Trends
2.3.2 Nanotechnology in Drug Delivery 麻豆原创 Drivers
2.3.3 Nanotechnology in Drug Delivery 麻豆原创 Challenges
2.3.4 Nanotechnology in Drug Delivery 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology in Drug Delivery Players by Revenue
3.1.1 Global Top Nanotechnology in Drug Delivery Players by Revenue (2018-2023)
3.1.2 Global Nanotechnology in Drug Delivery Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Nanotechnology in Drug Delivery 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanotechnology in Drug Delivery Revenue
3.4 Global Nanotechnology in Drug Delivery 麻豆原创 Concentration Ratio
3.4.1 Global Nanotechnology in Drug Delivery 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology in Drug Delivery Revenue in 2022
3.5 Nanotechnology in Drug Delivery Key Players Head office and Area Served
3.6 Key Players Nanotechnology in Drug Delivery Product Solution and Service
3.7 Date of Enter into Nanotechnology in Drug Delivery 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology in Drug Delivery Breakdown Data by Type
4.1 Global Nanotechnology in Drug Delivery Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Nanotechnology in Drug Delivery Forecasted 麻豆原创 Size by Type (2024-2029)
5 Nanotechnology in Drug Delivery Breakdown Data by Application
5.1 Global Nanotechnology in Drug Delivery Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Nanotechnology in Drug Delivery Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Nanotechnology in Drug Delivery 麻豆原创 Size (2018-2029)
6.2 North America Nanotechnology in Drug Delivery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2018-2023)
6.4 North America Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanotechnology in Drug Delivery 麻豆原创 Size (2018-2029)
7.2 Europe Nanotechnology in Drug Delivery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2018-2023)
7.4 Europe Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology in Drug Delivery 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Nanotechnology in Drug Delivery 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nanotechnology in Drug Delivery 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Nanotechnology in Drug Delivery 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanotechnology in Drug Delivery 麻豆原创 Size (2018-2029)
9.2 Latin America Nanotechnology in Drug Delivery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology in Drug Delivery 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Nanotechnology in Drug Delivery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Nanotechnology in Drug Delivery 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Access Pharmaceuticals
11.1.1 Access Pharmaceuticals Company Detail
11.1.2 Access Pharmaceuticals Business Overview
11.1.3 Access Pharmaceuticals Nanotechnology in Drug Delivery Introduction
11.1.4 Access Pharmaceuticals Revenue in Nanotechnology in Drug Delivery Business (2018-2023)
11.1.5 Access Pharmaceuticals Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Detail
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Nanotechnology in Drug Delivery Introduction
11.2.4 Alkermes Revenue in Nanotechnology in Drug Delivery Business (2018-2023)
11.2.5 Alkermes Recent Development
11.3 Aquanova
11.3.1 Aquanova Company Detail
11.3.2 Aquanova Business Overview
11.3.3 Aquanova Nanotechnology in Drug Delivery Introduction
11.3.4 Aquanova Revenue in Nanotechnology in Drug Delivery Business (2018-2023)
11.3.5 Aquanova Recent Development
11.4 Camurus
11.4.1 Camurus Company Detail
11.4.2 Camurus Business Overview
11.4.3 Camurus Nanotechnology in Drug Delivery Introduction
11.4.4 Camurus Revenue in Nanotechnology in Drug Delivery Business (2018-2023)
11.4.5 Camurus Recent Development
11.5 Capsulution Pharma
11.5.1 Capsulution Pharma Company Detail
11.5.2 Capsulution Pharma Business Overview
11.5.3 Capsulution Pharma Nanotechnology in Drug Delivery Introduction
11.5.4 Capsulution Pharma Revenue in Nanotechnology in Drug Delivery Business (2018-2023)
11.5.5 Capsulution Pharma Recent Development
11.6 Celgene
11.6.1 Celgene Company Detail
11.6.2 Celgene Business Overview
11.6.3 Celgene Nanotechnology in Drug Delivery Introduction
11.6.4 Celgene Revenue in Nanotechnology in Drug Delivery Business (2018-2023)
11.6.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Access Pharmaceuticals
Alkermes
Aquanova
Camurus
Capsulution Pharma
Celgene

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.